Vanguard Investments Australia’s CareDx CDNA Stock Holding History
Bought
Maintained
Sold
Other funds holding CDNA
DM
AIM
GS
Vanguard Investments Australia's CDNA Position: Q2 2026 in Review
Vanguard Investments Australia increased its CareDx (CDNA) stake by 22% in Q2 2026, buying an estimated $51.7K and bringing the position to 13,241 shares worth $377K. The position accounts for ﹤0.01% of the portfolio, ranked #1792.
Vanguard Investments Australia first reported a position in CDNA in Q1 2026 and has held it in 2 quarters since. 227 funds tracked by Wall St. Rank hold CDNA as of Q2 2026.
- Vanguard Investments Australia held 13,241 shares of CareDx worth $377K as of Q2 2026.
- Vanguard Investments Australia bought 2,376 CareDx shares in Q2 2026, an estimated $51.7K.
- CareDx made up ﹤0.01% of Vanguard Investments Australia's portfolio in Q2 2026, its #1792 holding.
- Vanguard Investments Australia first reported a position in CareDx in Q1 2026 and has held it in 2 quarters since.
- 227 funds tracked by Wall St. Rank held CareDx as of Q2 2026.
Based on Vanguard Investments Australia's 13F filing for Q2 2026, filed 13 Aug 2026.